Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-$10 bln U.S. battle for Britain's Morrisons heads for auction

Wed, 08th Sep 2021 07:49

* Morrisons agreed CD&R's 7 bln stg offer last month

* Rival suitor Fortress considering options

* All parties talking to Takeover Panel regarding auction

* Morrisons shares trading above CD&R's offer
(Adds detail, shares)

By James Davey

LONDON, Sept 8 (Reuters) - The $10 billion takeover battle
for British supermarket group Morrisons between two U.S.
private equity groups looks set to be decided by a rarely used
auction process.

Morrisons said on Wednesday it was in talks with Clayton,
Dubilier & Rice (CD&R), Fortress Investment Group and Britain's
takeover regulator about an auction to settle its future.

Last month, Morrisons agreed a 7 billion pound ($9.6
billion) offer from CD&R, which has former Tesco boss
Terry Leahy as a senior adviser. However, the rival consortium
led by Softbank-owned Fortress could still trump that
bid.

The fight for Britain's fourth-largest grocer after Tesco,
Sainsbury's and Asda, is the most high-profile looming
takeover amid a raft of bids and counter bids, reflecting
private equity's appetite for UK Plc.

Morrisons said that as neither bidder had declared its offer
final, it was talking to both of them and the Takeover Panel,
which governs M&A deals in the UK, about "an orderly framework
for the resolution of this competitive situation" - which would
typically be an auction.

Morrisons said shareholder meetings to vote on the CD&R
offer would be convened for around the week starting Oct. 18.

It said any auction would take place prior to these
shareholder meetings, on a date announced by the Takeover Panel.

Following completion of an auction, Morrisons shareholders
would vote on either a Fortress or a CD&R offer, depending on
which offer Morrisons' board recommended.

Morrisons said it expected a scheme document on CD&R's offer
to be posted to shareholders around Sept. 25.

CD&R's latest offer is worth 285 pence per Morrisons share -
a 60% premium to Morrisons' share price before takeover interest
emerged in mid-June.

Fortress, whose last offer was pitched at 272 pence a share,
said on Wednesday it "continues to consider its options."

Morrisons shares were trading at 291.3 pence at 1044 GMT,
indicating investors are hoping for a higher bid.

CD&R had no further comment.

AUCTION PROCESS

The Takeover Panel's standard auction structure is bidding
over a five-day period. However, if all parties are in agreement
a different structure can be used - for example bidding over
just one day.

Last month, the Takeover Panel set up an auction of British
inhaler company Vectura for suitors Philip Morris
International and U.S. private equity firm Carlyle.
However, in the event Carlyle decided not to raise its offer.

Morrisons, which trades from 497 stores and has a staff of
over 110,000, reiterated on Wednesday that in addition to the
financial terms of any offer it places "very significant
emphasis on the wider responsibilities of ownership", including
the importance of employees, customers, pension trustees and
suppliers.

Last month, the trustees of Morrisons' pension schemes
warned a takeover by either CD&R or Fortress could "materially
weaken" the security of the schemes if no additional protection
was agreed.

Morrisons is due to publish first half results on Thursday.

($1 = 0.7266 pounds)
(Reporting by James Davey
Editing by Guy Faulconbridge, Mark Potter and Jane Merriman)

More News
18 Dec 2020 08:12

Hikma rallies as it launches generic version of Glaxo asthma treatment

(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.

Read more
17 Dec 2020 18:10

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Read more
4 Dec 2020 13:05

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

Read more
30 Nov 2020 09:53

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Read more
30 Nov 2020 08:06

Vectura signs asthma treatment deal with Kinaset

(Sharecast News) - Vectura has signed a global licence and development deal with Kinaset Therapeutics of the US for the development and commercialisation of the VR588 pan-JAK asthma treatment.

Read more
20 Nov 2020 08:34

Court denies GSK appeal in Vectura intellectual property dispute

(Sharecast News) - Inhalation-focussed contract design and manufacture organisation Vectura Group announced on Friday that the United States Court of Appeals for the Federal Circuit has denied GlaxoSmithKline's (GSK) motions for judgment as a matter of law, a new trial on infringement, and for a new trial on damages in litigation concerning Vectura's US patent 8303991.

Read more
19 Nov 2020 20:25

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

Read more
28 Sep 2020 15:53

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

Read more
22 Sep 2020 19:34

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

Read more
15 Sep 2020 17:22

Vectura Revenue Slips But Swings To First Half Profit

Vectura Revenue Slips But Swings To First Half Profit

Read more
14 Sep 2020 17:21

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

Read more
2 Sep 2020 19:36

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

Read more
7 Jul 2020 16:35

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

Read more
9 Jun 2020 12:04

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

Read more
8 Jun 2020 15:00

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.